Sveriges mest populära poddar
Bloomberg Businessweek
Bloomberg Businessweek

Ozempic’s Success Is Bad News for Rivals

7 min•23 oktober 2023
Logga in för att spara

Om avsnittet

Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.

Fler avsnitt

Visa alla avsnitt av Bloomberg Businessweek

Schwab CEO: AI Creates New Pathways to Engage Clients

12 min

Amazon, Intel, Sandisk Report Earnings on Heels of Disappointing Alphabet Report

39 min

Charles Schwab Integrating AI Tools and Financial Planning

8 min

Alphabet Disappoints, Microsoft's Cloud Sales Grow: Earnings Live from Schwab IMPACT

37 min

Instant Reaction: Fed Stands Pat; Lisa Cook & Beth Hammack Dissent

22 min

Authors Talk 'What Games Teach Us About Making Products People Love'

12 min

Fed Meets Amidst "Most Confusing Economy Yet"

30 min

Epstein Haunts GOP in Midterms as Democrats Vow Fresh Probes

11 min

Anthropic Files for IPO in Global Race to Raise Cash for AI

40 min

Farmgirl Flowers Founder Sees Resilience Amid Fuel Cost, AI Uncertainty

11 min

Bloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.